Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

Transl Androl Urol. 2016 Dec;5(6):974-976. doi: 10.21037/tau.2016.11.06.

Authors

Paolo Grassi¹, Elena Verzoni¹, Alessia Mennitto¹, Giuseppe Procopio¹

Affiliation

¹ Department of Medical Oncology, Genitourinary Cancer Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.

No abstract available

Publication types

Editorial
Comment